+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Enhanced clopidogrel responsiveness in smokers: smokers' paradox is dependent on cytochrome P450 CYP1A2 status

Enhanced clopidogrel responsiveness in smokers: smokers' paradox is dependent on cytochrome P450 CYP1A2 status

Arteriosclerosis, Thrombosis, and Vascular Biology 31(3): 665-671

Observational studies have reported enhanced response to clopidogrel in smokers (the smokers' paradox). We examined whether genetic variations in the cytochrome and drug transporter system are associated with the effect of smoking on clopidogrel response. Clopidogrel on-treatment platelet reactivity (OPR) was measured in 1431 consecutive patients who underwent coronary angiography. Gene samples were available and genotyping was successful in 1123 patients. Nine candidate single-nucleotide polymorphisms in 5 cytochrome genes and 1 drug transporter gene were assessed. The mean OPR of the entire population was 241.9 ± 79.3 (P2Y(12) reaction units). Two hundred forty-nine (17%) smokers had lower OPR compared with 1182 (83%) nonsmokers (227.6 ± 76.0 versus 244.9 ± 79.7, P=0.001). Among the 9 single-nucleotide polymorphisms, only CYP1A2 showed a genotype-dependent change in the effect of smoking on OPR. After adjustment for possible confounding factors, cigarette smoking was associated with a lower OPR by -19 P2Y(12) reaction units (P=0.009) and lower risk for high OPR (odds ratio [OR], 0.48; 95% CI, 0.31 to 0.74) in the AA and CA genotypes but not in the CC genotype. Enhanced clopidogrel response in smokers, known as the smokers' paradox, is not universal but was observed only in cytochrome P450 CYP1A2 (-163C>A) A-allele carriers, suggesting a genotype-dependent effect of smoking on clopidogrel responsiveness.

(PDF emailed within 0-6 h: $19.90)

Accession: 052982825

Download citation: RISBibTeXText

PMID: 21148426

DOI: 10.1161/ATVBAHA.110.217182

Related references

Enhanced clopidogrel response in smokers is reversed after discontinuation as assessed by VerifyNow assay: additional evidence for the concept of 'smokers' paradox'. Heart 98(13): 1000-1006, 2012

Cytochrome P450 gene expression and protein activity in bronchoalveolar macrophages and bronchial epithelial cells of smokers and non-smokers. Toxicology Letters (Shannon) 144(Suppl 1): s103-s104, September, 2003

DNA adducts, expression of cytochrome P450 and glutathione 3-transferase and GSTM1/GSTP1 polymorphisms in broncho-alveolar macrophages of smokers and non-smokers. Mutation Research 379(1 SUPPL 1): S158, 1997

Expression of cytochromes P450 1A1 and 1B1 in human lung from smokers, non-smokers, and ex-smokers. Toxicology and Applied Pharmacology 199(3): 210-219, 2004

Determination of the nicotine metabolites cotinine and trans-3'-hydroxycotinine in biologic fluids of smokers and non-smokers using liquid chromatography-tandem mass spectrometry: biomarkers for tobacco smoke exposure and for phenotyping cytochrome P450 2A6 activity. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 879(3-4): 267-276, 2011

A distribution study of CYP1A2 phenotypes among smokers and non-smokers in a cohort of healthy Caucasian volunteers. European Journal Of Clinical Pharmacology. 53(5): 361-367,., 1998

Oxidative stress status in smokers, ex-smokers and non-smokers measuring three nucleic acid oxidation adducts and isoprostane F2alpha using LC/MS/MS. Free Radical Biology & Medicine 35(Supplement 1): S34, 2003

Biological effect of increased maintenance dose of clopidogrel in cardiovascular outpatients and influence of the cytochrome P450 2C19*2 allele on clopidogrel responsiveness. Thrombosis Research 121(4): 463-468, 2007

Smoking patterns among social contacts of smokers ex smokers and nerve smokers the doctors helping smokers study. Preventive Medicine 16(5): 626-635, 1987

The smokers paradox Why outcome after coronary angioplasty is better in current smokers?. European Heart Journal 19(ABST SUPPL ): 117, 1998

Evidence for more effective fibrinolysis in cigarette smokers following thrombolysis for acute myocardial infarction-A new hypothesis in the smokers paradox. Journal of the American College of Cardiology 33(2 SUPPL A): 367A, 1999

Short-term mortality of habitual cigarette smokers after acute myocardial infarction The smokers paradox in a statewide study. European Heart Journal 20(ABSTR SUPPL ): 236, 1999

CYP1A2 and NAT2 phenotyping and 3-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in smokers and non-smokers. Toxicology and Applied Pharmacology 213(3): 198-206, 2006